Non-invasive cardiac study in diabetic Nigerians using systolic time intervals. 1985

O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase

Non-invasive cardiac studies using systolic time intervals were performed on 89 diabetic Nigerians and 45 non-diabetic controls, to investigate possible preclinical abnormality of left ventricular function. There was no significant difference in the pre-ejection period to left ventricular ejection time ratio (PEP/LVET) between the patients and controls: 0.373 +/- 0.011 vs 0.365 +/- 0.013 (P = 0.688). Patients at higher risk for developing significant vascular disease i.e. those with peripheral vascular insufficiency, those in higher socio-economic class and those with disease duration of 10 or more years had the highest mean values of PEP/LVET (0.403, 0.403 and 0.412 respectively). However, these values did not reach a level of significance. There was no correlation between PEP/LVET and age, body mass index, duration of diabetes, total or HDL cholesterol and the HDL to total cholesterol ratio. Because recent reports have related diabetic cardiomyopathy to angiopathic disease in diabetes, these results suggest that Nigerian patients, who like most other black African diabetics show little susceptibility to severe vascular complications of diabetes may enjoy some protection from a preclinical abnormality of left ventricular function as well.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D009549 Nigeria A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja. Federal Republic of Nigeria
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
May 1978, Nigerian medical journal : journal of the Nigeria Medical Association,
O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
July 1975, Ugeskrift for laeger,
O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
January 1976, Acta medica Scandinavica,
O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
October 1983, Methods and findings in experimental and clinical pharmacology,
O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
January 1980, Acta cardiologica,
O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
October 1978, Archives of internal medicine,
O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
January 1971, Modern concepts of cardiovascular disease,
O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
February 1971, Modern concepts of cardiovascular disease,
O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
July 1987, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
O O Famuyiwa, and O J Odia, and B O Osotimehin, and A D Adenle, and A O Falase
October 1973, California medicine,
Copied contents to your clipboard!